Absence of T cells confers increased pulmonary arterial hypertension and vascular remodeling.
about
Molecular pathogenesis of pulmonary arterial hypertensionPathobiology of pulmonary arterial hypertension and right ventricular failureLeukotrienes in pulmonary arterial hypertensionPotential contribution of phenotypically modulated smooth muscle cells and related inflammation in the development of experimental obstructive pulmonary vasculopathy in ratsPulmonary vascular disease related to hemodynamic stress in the pulmonary circulation.Treatment-related biomarkers in pulmonary hypertensionSustained hypoxia promotes the development of a pulmonary artery-specific chronic inflammatory microenvironmentA brief overview of mouse models of pulmonary arterial hypertension: problems and prospects.Blocking macrophage leukotriene b4 prevents endothelial injury and reverses pulmonary hypertension.T lymphocyte subset abnormalities in the blood and lung in pulmonary arterial hypertension.Severe pulmonary arterial hypertension induced by SU5416 and ovalbumin immunization.Basic science of pulmonary arterial hypertension for clinicians: new concepts and experimental therapiesInflammation and immunity in the pathogenesis of pulmonary arterial hypertensionCXC-chemokine ligand 10 in idiopathic pulmonary arterial hypertension: marker of improved survivalIndispensable roles of OX40L-derived signal and epistatic genetic effect in immune-mediated pathogenesis of spontaneous pulmonary hypertension.Nuclear factor κB inhibition reduces lung vascular lumen obliteration in severe pulmonary hypertension in rats.Increased regulatory and decreased CD8+ cytotoxic T cells in the blood of patients with idiopathic pulmonary arterial hypertensionInvolvement of mast cells in monocrotaline-induced pulmonary hypertension in rats.Perivascular T-cell infiltration leads to sustained pulmonary artery remodeling after endothelial cell damage.Elafin Reverses Pulmonary Hypertension via Caveolin-1-Dependent Bone Morphogenetic Protein Signaling.Copper dependence of angioproliferation in pulmonary arterial hypertension in rats and humansImproved pulmonary vascular reactivity and decreased hypertrophic remodeling during nonhypercapnic acidosis in experimental pulmonary hypertension.Interplay of macrophages and T cells in the lung vasculature.HIV-1, reactive oxygen species, and vascular complicationsBone morphogenetic protein signaling in vascular disease: anti-inflammatory action through myocardin-related transcription factor APathogenic mechanisms of pulmonary arterial hypertension.Pulmonary arterial remodeling induced by a Th2 immune responseMolecular pathogenesis of pulmonary arterial hypertensionUpdate in pulmonary arterial hypertension 2007.Runx-CBFbeta complexes control expression of the transcription factor Foxp3 in regulatory T cells.Regulation of hypoxia-induced pulmonary hypertension by vascular smooth muscle hypoxia-inducible factor-1α.Prolonged activation of IL-5-producing ILC2 causes pulmonary arterial hypertrophyPulmonary hypertension: advances in pathogenesis and treatment.The effects of antiangiogenic compound SU5416 in a rat model of pulmonary arterial hypertension.Regulatory T cells and pulmonary hypertensionPulmonary arterial hypertension: challenges in translational research and a vision for change.Novel investigational therapies for treating pulmonary arterial hypertension.Molecular pathogenesis and current pathology of pulmonary hypertension.Lung Circulation.Challenges and opportunities in treating inflammation associated with pulmonary hypertension.
P2860
Q24634317-01455869-3C26-4F23-9821-B04202228EF3Q26821779-2CB46691-7679-41D0-A533-FF84A8E85DC1Q26853496-736B2396-1868-47DC-8DEE-FE32FEE7D69EQ27313498-2A955CCD-37CA-446B-BC48-C95EF0A3F71BQ27687091-9BA10525-BD92-4FBC-826D-7BFF7A7E4CCDQ28081276-D0C09F29-F4B6-4D85-A83D-E3316A278E32Q29346986-40B95685-9128-4912-A9CA-9F991FD8ECB0Q30544892-6406945A-45BF-4226-A528-9B023A595E0EQ33593640-0F8FB88B-C4EF-429F-90CC-7A738AC69F75Q33679052-6CD6FBA5-EBA0-41BC-9CFF-ED99EA5BB209Q33764990-AF8A3830-D028-4D80-A120-ACEA0F594072Q33849207-49B46AF4-15B8-4E9B-B223-9E3B59EC1381Q33898213-429CE5DE-219A-42B6-A171-967423971518Q33917277-FD995B48-930B-4FD0-81A3-DFC50E4BC356Q34101823-1A30570C-644D-405E-B306-6DE0155DD937Q34305561-F3487D6D-23EF-44E6-A894-6E1EC944D2A5Q34536425-2788DC66-EB8E-4D46-BF21-47EC793A6C3CQ35014605-4A6820CA-2083-4582-9FAD-93F3B6379AF2Q35173533-FB7277B7-E13F-4493-83DA-A27276A6F9F2Q35766693-50B73707-878D-4697-A774-B61D01C29498Q35991277-6EA6B637-ED5A-4B98-B193-8315F389317FQ35994471-43EAE7B5-1680-4894-9F85-CE7CF3393E53Q35994814-BF287454-88F6-4E72-BF6A-1DDE79D1B2E8Q36040759-3921591A-80B5-4F5D-BC08-81CA3363AF82Q36201860-886F92F3-5FF7-4876-A62A-DFAE0D55F662Q36447388-BE3573E1-9ABB-4CB1-BFCD-D13414C352EDQ36502869-6C4F81BB-7476-4681-BA05-2BB3274E5280Q36736065-8F3240B2-0BD5-4AF9-B645-DCE289EF650EQ37100702-36EF1453-BA2B-4B88-9F0C-96ADDBAFCBC8Q37394198-1F16B25F-DD52-4249-9678-0C6234C56A59Q37688525-0AA54A0E-8608-497D-B8DC-47A4A7EEE4F6Q37730806-DF397B8F-819D-4859-A27E-9CD653916D7CQ37744182-CDAA515D-B268-4C95-ADB8-74F6365EA01EQ37813372-FEB48BC9-6858-4FB4-B3F0-AD664E04D1ADQ38027723-649AB01E-C0D5-4A11-AD4F-78F01CF97C76Q38155079-069811CC-F512-41C0-AFA0-8DEF44B1E43AQ38612061-9D80E2F5-B5C3-496F-A1A4-B60B7E327004Q38676413-889A819C-BD0A-480B-9B07-0EFDA4AEA338Q38804579-8A98F764-AA37-4203-A165-57CAA3B4317DQ38812727-40DC18C7-4348-4368-A23B-D4D6944532F4
P2860
Absence of T cells confers increased pulmonary arterial hypertension and vascular remodeling.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年学术文章
@wuu
2007年学术文章
@zh-cn
2007年学术文章
@zh-hans
2007年学术文章
@zh-my
2007年学术文章
@zh-sg
2007年學術文章
@yue
2007年學術文章
@zh
2007年學術文章
@zh-hant
name
Absence of T cells confers inc ...... nsion and vascular remodeling.
@ast
Absence of T cells confers inc ...... nsion and vascular remodeling.
@en
type
label
Absence of T cells confers inc ...... nsion and vascular remodeling.
@ast
Absence of T cells confers inc ...... nsion and vascular remodeling.
@en
prefLabel
Absence of T cells confers inc ...... nsion and vascular remodeling.
@ast
Absence of T cells confers inc ...... nsion and vascular remodeling.
@en
P2093
P2860
P1476
Absence of T cells confers inc ...... nsion and vascular remodeling.
@en
P2093
Carlyne Cool
Donatas Kraskauskas
Jane E Parr
Kathy Wood
Laimute Taraseviciene-Stewart
Mark R Nicolls
Nana Burns
Norbert F Voelkel
Robertas Scerbavicius
Susan A Boackle
P2860
P304
P356
10.1164/RCCM.200608-1189OC
P407
P577
2007-04-05T00:00:00Z